GENE ONLINE|News &
Opinion
Blog

2022-03-09| SpecialStartups

Cure or Poison? New Ventures Go IPO Continuously As “Psychedelics” Enter the Mental Health Market

by GeneOnline
Share To
Several start-up companies have been actively engaged in this flourishing field of drug research and development in recent years. They have successively gained the breakthrough therapy designation from the FDA or carried out IPOs. The following are four notable biotechnology companies around the world: Compass Pathways, Atai Life Sciences, MindMed, and Cybin.

It's free! Log in now to read

LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!